1 / 28

THROMBOLYSIS

THROMBOLYSIS. Acute MI. Reducing delay is our major challenge. Delay in context : Delay thrombolysis by 1 hour = 21 deaths/1000 patients in one month (and probably as many again die in 2 years) Rawles 1998. How to establish reperfusion. Thrombolysis Coronary Angioplasty ( PTCA).

hallie
Download Presentation

THROMBOLYSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. THROMBOLYSIS

  2. Acute MI Reducing delay is our major challenge • Delay in context : • Delay thrombolysis by 1 hour = 21 deaths/1000 patients in one month (and probably as many again die in 2 years) • Rawles 1998

  3. How to establish reperfusion • Thrombolysis • Coronary Angioplasty ( PTCA)

  4. AAC/AHA Guidelines for Thrombolysis • All patients who have symptoms suggesting AMI • Within 12 hours of onset of symptoms • ECG changes of AMI (STEMI, new BBB) • No contraindications

  5. Thrombolysis : What to give ? • Streptokinase : 1.5MU in 100 ml. 5% Dextrose/0.9% saline over 60 mins. • tPA : 15 mg bolus , followed by 50mg over 60 mins.& residual 35 mg over 30 mins. • Reteplase : 10 IU bolus, then 10 IU after 30 mins. • Tenecteplase : 30-50mg IV bolus • Door-to-needle time – 30 min

  6. Thrombolytics Streptokinase AlteplaseReteplaseTenecteplase 1.5 MU over Up to 100 mg 10 U IV x 2 30-50 mg 30-60 min eachin 90 min over 2 min Patency 90 min 50% 75% 60-70% 75%

  7. Problems with thrombolysis • Only 30 % pts.recieve it • Patency rate 66% (Tenecteplase) 63% (Reteplase) ; 54% (tPA); ! 30% (STK) • 30% reocclude in 3 months • Not for haemodynamically unstable pts. • Residual stenosis

  8. Nightmares in thrombolysis

  9. Trials of STK on AMI

  10. Which thrombolytic is best ?

  11. GUSTO trial : Patency

  12. Effect of Thrombolysis on Mortality

  13. Does thrombolysis play a role in NSTEMI ( TIMI IIIb)

  14. Time to ThrombolysisInt J Cardiol 1995; 49: 33-37 EMIP MITI GREAT Benefit Gradient 23 / 1000 / Hour

  15. Can we give prehospital thrombolysis ?

  16. 2008 guidelines ACC/AHA • The use of prehospital 12-lead electrocardiography is encouraged to increase the efficiency of care for STEMI.

  17. Rationale of prehospital thrombolysis

  18. Time saved by prehospital thrombolysis ( min.) • McNeil 68 • Castaigne 60 • Barbash 40 • Schofer 43 • GREAT 130 • McAleer 34 • EMIP 55 • MITI 33

  19. Prehospital thrombolysis is beneficial

  20. Prehospital vs Hospital thrombolysis

  21. Feasibility of prehospital thrombolysis • For whom ? :STEMI / New BBB No age limit • What setting ? :home to hospital>90 min • Major problems : VF (2.5 vs 1.6%) Shock ( 6.3 vs 3.9%) • Which agent?: Antistreplase; Reteplase • Skills / Equipment?: Trained paramedic, 12-lead ECG, well-developed emergency medical services

  22. Thrombolysis : do not use • Active internal bleeding • CVA ~ 2 months • Known CNS neoplasm • Recent trauma / Major surgery ~ 2 wks. • Pregnancy • BP > 180 / 110 • Prolonged CPR > 5-10 mins

  23. Pulmonary EmbolismTHROMBOLYTIC THERAPY • Thrombolysis • (with iv Steptokinase, Urokinase, rTPA) leads to • Quicker resolution of clot . • Reverse RT. Heart failure & Improved haemodynamics • Probably improved long term outcomes • Effective for up to 10-14 days after symptoms • But NOT • Reduced mortality • Reduced PE recurrence

  24. Dose Schedule in PE • 1. STK - IV bolus 250,000 U over 30‘ followed by infusion 100,000U/hr for 12-24hrs • 2. rtPA – IV bolus of 15 mg in 10’ followed by 85 mg in next 2hrs <total= 100mg> to be followed by heparin on completion of rtPA. • 3. UK - 4400 U/kg for 10’ by 4400 U/kg/hr for 24hrs. • Drawbacks- danger of severe & often fatal bleeding: ICH 1-3% , failed thrombolysis 8-10%

  25. Acute Ischaemic Stroke: Thrombolysis • rtPA is the treatment of choice for thrombolysis in acute stroke. rtPA is the treatment of choice for patients who present within 3(4.5) hours of the onset of stroke symptoms. • Treatment with streptokinase is not recommended, and reteplase, urokinase, and other thrombolytic agents should not be used outside of the setting of a clinical trial. • Intra-arterial thrombolysis may be used for patients with occlusions of the middle cerebral artery who can be treated within 6 hours of symptom onset.

  26. Acute IschaemicStroke:IVtPA • 0.9mg/Kg max 90mg infused over 60 min • 10% dose administered as initial IV bolus over 1 min • Following tPA no aspirin, heparin, or warfarin for 24 hours

More Related